Not applicableLooking for participantsNCT06593964What this trial is testingTACE With Thermosensitive Nanogel Versus Embosphere for HCCWho this might be right forUnresectable Hepatocellular Carcinoma Zhongda Hospital 188
Large-scale testing (Phase 3)Looking for participantsNCT05476432What this trial is testingHAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority StudyWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 300
Testing effectiveness (Phase 2)Study completedNCT00142467What this trial is testingGemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Massachusetts General Hospital 33
Testing effectiveness (Phase 2)Ended earlyNCT05103904What this trial is testingLenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver TransplantWho this might be right forRecurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8+5 more Emory University 3
Early research (Phase 1)Study completedNCT01183663What this trial is testingLenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)Who this might be right forAdvanced Cancers M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Study completedNCT00107536What this trial is testingLapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more National Cancer Institute (NCI) 26
Not applicableStudy completedNCT02072486What this trial is testingSorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryWho this might be right forAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Hepatocellular CarcinomaStage III Childhood Hepatocellular Carcinoma+6 more Roswell Park Cancer Institute 30
Not applicableNot Yet RecruitingNCT07337031What this trial is testingA Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver CancerWho this might be right forPrimary Hepatocellular CarcinomaUnresectable Liver Cancer Eastern Hepatobiliary Surgery Hospital 193
Large-scale testing (Phase 3)UnknownNCT04667351What this trial is testingHAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority TrialWho this might be right forHepatoCellular Carcinoma Sun Yat-sen University 400
Early research (Phase 1)WithdrawnNCT02989870What this trial is testingSorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular CarcinomaWho this might be right forHepatoCellular CarcinomaUnresectable HepatoCellular CarcinomaLiver Cancer H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT05497453What this trial is testingEvaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC OncogeneWho this might be right forHepatocellular CarcinomaSolid TumorHepatocellular Carcinoma Non-resectable+4 more Omega Therapeutics 24
Testing effectiveness (Phase 2)Ended earlyNCT04541173What this trial is testingStudy of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)Who this might be right forHepatocellular Carcinoma Aiwu Ruth He, MD 6
Not applicableEnded earlyNCT01817205What this trial is testingCombined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Chinese University of Hong Kong 8
Early research (Phase 1)Study completedNCT02143401What this trial is testingNavitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsWho this might be right forCirrhosisHepatitis B InfectionHepatitis C Infection+6 more National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)UnknownNCT00054951What this trial is testingSafety and Efficacy of Doxorubicin Adsorbed to Magnetic BeadsWho this might be right forHepatocellular Carcinoma FeRx 30
Not applicableLooking for participantsNCT07717437What this trial is testingDRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.Who this might be right forLiver CancerLiver Metastases Maastricht University Medical Center 350
Not applicableStudy completedNCT02685631What this trial is testingYttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN StudyWho this might be right forLocalized Non-Resectable Adult Liver Carcinoma Vanderbilt-Ingram Cancer Center 1,653
Early research (Phase 1)Study completedNCT01040559What this trial is testingChemoembolisation of Non Resectable, Non Metastatic Hepatocellular CarcinomasWho this might be right forCarcinoma, Hepatocellular Centre Hospitalier Universitaire Dijon 18
Testing effectiveness (Phase 2)Study completedNCT01639352What this trial is testingPhase II Trial of SOM230 in Patients With Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Lynn Feun 20
Early research (Phase 1)Study completedNCT04338685What this trial is testingA Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic MetastasesWho this might be right forCarcinoma, HepatocellularBiliary Tract CancerSecondary Liver Cancer+1 more Hoffmann-La Roche 55